Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.

Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
10 Sep 2019
Historique:
entrez: 20 9 2019
pubmed: 20 9 2019
medline: 20 9 2019
Statut: epublish

Résumé

[This corrects the article DOI: 10.18632/oncotarget.17747.].

Identifiants

DOI: 10.18632/oncotarget.27198 PMID: 31534634 PMC: PMC6739213
pubmed: 31534634
doi: 10.18632/oncotarget.27198
pii: 27198
pmc: PMC6739213
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

5493

Commentaires et corrections

Type : ErratumFor

Auteurs

Anne-Sophie Chretien (AS)

Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
Immunomonitoring Platform, Institut Paoli-Calmettes, Marseille, France.

Cyril Fauriat (C)

Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
Immunomonitoring Platform, Institut Paoli-Calmettes, Marseille, France.

Florence Orlanducci (F)

Immunomonitoring Platform, Institut Paoli-Calmettes, Marseille, France.

Jerome Rey (J)

Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.

Gaelle Bouvier Borg (GB)

Beckman Coulter Immunotech, Marseille, France.

Emmanuel Gautherot (E)

Beckman Coulter Immunotech, Marseille, France.

Samuel Granjeaud (S)

Systems Biology Platform, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.

Clemence Demerle (C)

Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
Immunomonitoring Platform, Institut Paoli-Calmettes, Marseille, France.

Jean-François Hamel (JF)

Biostatistics and Methodology Department, CHU Angers, Angers, France.

Adelheid Cerwenka (A)

Innate Immunity Group, German Cancer Research Center, Heidelberg, Germany.

Elke Pogge von Strandmann (EP)

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Clinic for Hematology, Oncology and Immunology, Experimental Tumor Research, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.

Norbert Ifrah (N)

Hematology Department, CHU Angers, Angers, France.

Catherine Lacombe (C)

GOELAMStheque, FILO French Innovative Leukemia Organization, Cochin Hospital, APHP, Paris, France.

Pascale Cornillet-Lefebvre (P)

Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Reims, Reims, France.

Jacques Delaunay (J)

Service d'Hématologie, Centre Catherine de Sienne, Nantes, France.

Antoine Toubert (A)

INSERM UMRS-1160, Univ Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Immunology and Histocompatibility Department, Hôpital Saint-Louis, APHP, Paris, France.

Christine Arnoulet (C)

Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
Biopathology Department, Institut Paoli Calmettes, Marseille, France.

Norbert Vey (N)

Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
Hematology Department, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.

Daniel Olive (D)

Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, UM 105, Marseille, France.
Immunomonitoring Platform, Institut Paoli-Calmettes, Marseille, France.

Classifications MeSH